XML 78 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
JOINT VENTURE (Tables)
 3 Months Ended
Mar. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Interest in Variable Interest Entity and Maximum Exposure The table below summarizes the Company’s interest in Nautilus and the Company’s maximum exposure to loss as a result of its involvement with the VIE as of March 31, 2024 (in thousands, except for percentages):
Entity% OwnershipInitial
Investment		Additional
Investment, Net		Net loss
Inception
to Date		Company’s
Variable
Interest in
Entity		Commitment to
Future
Additional
Contributions
(1)		Company’s
Maximum
Exposure to Loss
in Entity (2)
Nautilus25.0 %$18,000 $95,131 $21,265 $91,866 $— $91,866 
(1)The Members may mutually agree on changes to the Nautilus facility, which could increase the amount of contributions the Company is required to provide. The Members may seek alternate financing for the Nautilus facility, which could reduce the amount of investments each Member may be required to provide.
(2)The maximum exposure at March 31, 2024 is determined by adding the Company’s variable interest in the entity and any explicit or implicit arrangements that could require the Company to provide additional financial support. The amount represents the contractually required capital contributions of the Company which were required for the initial phase of the Nautilus facility buildout.
Equity Method Investments The condensed results of operations for the three months ended March 31, 2024 and 2023 and the condensed financial position as of March 31, 2024 and December 31, 2023 of Nautilus are summarized below (in thousands):
Three Months Ended
March 31, (1)
20242023
Condensed statement of operations information:  
Revenue$41,740 $9,106 
Operating expense26,322 12,137 
Net income (loss)$15,418 $(3,031)
March 31, 2024 (1) December 31, 2023 (1)
Condensed balance sheet information:  
Current assets$12,560 $12,406 
Noncurrent assets158,946 171,245 
Total assets$171,506 $183,651 
Current liabilities$13,289 $13,149 
Noncurrent liabilities29,755 29,493 
Equity128,462 141,009 
Total liabilities and equity$171,506 $183,651 
(1)The condensed statements of operations information for the three months ended March 31, 2024 and 2023 and the condensed balance sheet information as of March 31, 2024 and December 31, 2023 reflect the impact of the Talen-estimated fair value measurements of Nautilus which, resulting from the application of ASC 805, Business Combinations, have been pushed down to the books and records of Nautilus by Talen, as discussed above. The Company’s basis in the assets and liabilities of Nautilus continue to be recorded at historical value on the accompanying consolidated balance sheets.